Company Profile

OrthoSystems Inc (AKA: Advanced Resonance Technologies Inc)
Profile last edited on: 6/19/2019      CAGE: 3M6A2      UEI: P6QQJF456L83

Business Identifier: Diagnostic tools for detection of chemical and biological targets
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2-212 Center For Science & Technology
Syracuse, NY 13244
   (315) 443-5925
Location: Single
Congr. District: 24
County: Onondaga

Public Profile

OrthoSystems Inc, formerly known as Advanced Resonance Technologies Inc and spun out of technology developed at Syracuse University, is a biotechnology company developing switch technology capable of a) creating rapid diagnostic tools for detection of chemical and biological targets, and b) leveraging this diagnostic platform for drug discovery applications. OrthoSwitch, OrthoSystems' platform technology, has demonstrated the ability of transducing molecular recognition of biological targets into a real-time (seconds) optical signal for identifying environmental and terrorist released contaminants in liquid systems. OrthoSwitch solutions are built on patent-pending biotechnology based on years of leading-edge biological research and industry partnerships at Syracuse University

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2011 2 NIH $1,781,638
Project Title: Simple Dna/Rna Probes For Protein Targets
2010 1 NIH $195,561
Project Title: Aptamer Probes For Epigenetic Peptide Targets
2009 2 NIH $1,249,198
Project Title: Microarray chips for rapid detection of high affinity nucleic acid sequences
2006 2 NIH $853,149
Project Title: Improved NMR Sample Tubes
2005 2 NIH $851,587
Project Title: OrthoSwitch Probes for High Throughput Screening

Key People / Management

  Philip N Borer -- President